Historical Valuation
Dolby Laboratories Inc (DLB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.91 is considered Undervalued compared with the five-year average of 22.11. The fair price of Dolby Laboratories Inc (DLB) is between 105.92 to 130.29 according to relative valuation methord. Compared to the current price of 63.62 USD , Dolby Laboratories Inc is Undervalued By 39.94%.
Relative Value
Fair Zone
105.92-130.29
Current Price：63.62
39.94%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Dolby Laboratories Inc (DLB) has a current Price-to-Book (P/B) ratio of 2.31. Compared to its 3-year average P/B ratio of 3.10 , the current P/B ratio is approximately -25.31% higher. Relative to its 5-year average P/B ratio of 3.20, the current P/B ratio is about -27.69% higher. Dolby Laboratories Inc (DLB) has a Forward Free Cash Flow (FCF) yield of approximately 7.20%. Compared to its 3-year average FCF yield of 4.62%, the current FCF yield is approximately 55.79% lower. Relative to its 5-year average FCF yield of 4.40% , the current FCF yield is about 63.64% lower.
P/B
Median3y
3.10
Median5y
3.20
FCF Yield
Median3y
4.62
Median5y
4.40
Competitors Valuation Multiple
AI Analysis for DLB
The average P/S ratio for DLB competitors is 7.02, providing a benchmark for relative valuation. Dolby Laboratories Inc Corp (DLB.N) exhibits a P/S ratio of 4.28, which is -39.02% above the industry average. Given its robust revenue growth of 0.73%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for DLB
1Y
3Y
5Y
Market capitalization of DLB increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of DLB in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is DLB currently overvalued or undervalued?
Dolby Laboratories Inc (DLB) is now in the Undervalued zone, suggesting that its current forward PE ratio of 14.91 is considered Undervalued compared with the five-year average of 22.11. The fair price of Dolby Laboratories Inc (DLB) is between 105.92 to 130.29 according to relative valuation methord. Compared to the current price of 63.62 USD , Dolby Laboratories Inc is Undervalued By 39.94% .
What is Dolby Laboratories Inc (DLB) fair value?
DLB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Dolby Laboratories Inc (DLB) is between 105.92 to 130.29 according to relative valuation methord.
How does DLB's valuation metrics compare to the industry average?
The average P/S ratio for DLB's competitors is 7.02, providing a benchmark for relative valuation. Dolby Laboratories Inc Corp (DLB) exhibits a P/S ratio of 4.28, which is -39.02% above the industry average. Given its robust revenue growth of 0.73%, this premium appears unsustainable.
What is the current P/B ratio for Dolby Laboratories Inc (DLB) as of Jan 09 2026?
As of Jan 09 2026, Dolby Laboratories Inc (DLB) has a P/B ratio of 2.31. This indicates that the market values DLB at 2.31 times its book value.
What is the current FCF Yield for Dolby Laboratories Inc (DLB) as of Jan 09 2026?
As of Jan 09 2026, Dolby Laboratories Inc (DLB) has a FCF Yield of 7.20%. This means that for every dollar of Dolby Laboratories Inc’s market capitalization, the company generates 7.20 cents in free cash flow.
What is the current Forward P/E ratio for Dolby Laboratories Inc (DLB) as of Jan 09 2026?
As of Jan 09 2026, Dolby Laboratories Inc (DLB) has a Forward P/E ratio of 14.91. This means the market is willing to pay $14.91 for every dollar of Dolby Laboratories Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Dolby Laboratories Inc (DLB) as of Jan 09 2026?
As of Jan 09 2026, Dolby Laboratories Inc (DLB) has a Forward P/S ratio of 4.28. This means the market is valuing DLB at $4.28 for every dollar of expected revenue over the next 12 months.